findmyKOL

Srivadee Oravivattanakul, MD

Basic profile

Neurology

ORCIDNone on fileNPI↗
✓ Full record
RegionAllen, TX · South CentralSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL type: RegionalLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Srivadee Oravivattanakul is a Neurology physician. OpenAlex indexes 23 publications with 340 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
23publications

Distinct works indexed by OpenAlex.

340citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
17companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

907 Panther Ln
Allen, TX 750134879

Telephone

612-423-6261

Provider last certified this registry record 10 Jan 2022.

View the NPPES registry record

Industry payments

17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    95.6%
    Cholinesterase Inhibitor21%
    Donepezil Hcl82%Rivastigmine13%Pyridostigmine Bromide5%
    Part D<11 patients
    Gabapentinoids16.3%
    Gabapentin61%Pregabalin39%
    Part D≥49 patients

    + 16 more classes in this area

  • Blood & clotting

    2.4%
    P2Y12 inhibitor1.6%
    Clopidogrel100%
    Part D<11 patients
    Factor Xa inhibitor0.8%
    Eliquis100%
    Part D<11 patients
  • Musculoskeletal

    2%
    gamma-Aminobutyric Acid-ergic Agonist1.1%
    Baclofen100%
    Part D<11 patients
    Central alpha-2 Adrenergic Agonist0.9%
    Tizanidine Hcl100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”